Skip to content

Randomized Trial Comparing DR-CRUSH Technique With Provisional Stenting for High-Risk Coronary Bifurcation Lesions

Randomized Trial Comparing DR-CRUSH Technique With Provisional Stenting for High-Risk Coronary Bifurcation Lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099768
Enrollment
Unknown
Registered
2025-03-28
Start date
2025-03-31
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Treatment Group:DR-CRUSH technique
Control Group:Provisional two-stent technique

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinical criteria: (1) Male or female with age >=18 years and =1.5mm) and needs to be stented; (2) The anatomical characteristics of the coronary arteries allow the stent to be delivered to the target lesion site. (3) High-risk bifurcation lesions: baseline V-RESOLVE score >=14 points.

Exclusion criteria

Exclusion criteria: 1. The subject is allergic to the relevant devices used in the test (stent alloy, drug coating, etc.); 2. Subjects plan to undergo other surgeries within 6 months after PCI; 3. Subject has the following conditions: (1) Have other serious diseases (malignant tumors, heart failure, etc.), and have a life expectancy of less than 12 months; (2) Alcohol dependence, caffeine dependence, drug addiction, etc.; (3) have other surgery/treatment plans that may affect the subject's compliance with this study; 4. Subject has coagulation dysfunction; 5. The subject is participating in other clinical trials and has not yet reached the study endpoint; 6. Subject plans to participate in other drug/device clinical trials in the next 12 months; 7. Female subjects plan to become pregnant/give birth in the next 12 months; 8. Subject is pregnant or lactating; 9. Subject's ejection fraction 2.0mg/dl (176.82umol/L);

Design outcomes

Primary

MeasureTime frame
Myocardial Infarction;Target Vessel Revascularization;All-cause Death;

Countries

China

Contacts

Public ContactDong Zhang

Fuwai Hospital, Chinese Academy of Medical Sciences

pumczhangdong@126.com+86 188 1048 8380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026